Key result
Paeonol improved cardiac function, inhibited apoptosis, and reduced cardiac hypertrophy in mice with transverse aortic constriction-induced heart failure via the ERK1/2/JNK pathway.
Why the study?
Paeonol has anti-inflammatory and antioxidant effects, but its cardioprotective effect was unclear.
Does paeonol attenuate heart failure in a TAC-induced mouse model?
RCT
Randomly divided
Does paeonol attenuate heart failure in a TAC-induced mouse model?
Paeonol attenuates TAC-induced heart failure in mice by inhibiting apoptosis and cardiac hypertrophy via regulation of the ERK1/2/JNK pathway.
No clinical use of paeonol yet; leaves open translation of ERK1/2/JNK effects to human heart failure.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted an RCT in Transverse aortic constriction (TAC)-induced heart failure. Paeonol vs. Sham and TAC control groups was evaluated. Paeonol improved cardiac function, inhibited apoptosis, and reduced cardiac hypertrophy in mice with transverse aortic constriction-induced heart failure via the ERK1/2/JNK pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: